Status:
COMPLETED
Enhanced Recovery After Thoracic Surgery
Lead Sponsor:
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Conditions:
Enhanced Recovery After Thoracic Surgery Protocol
C-reactive Protein
Eligibility:
All Genders
18-80 years
Brief Summary
Despite significant advances in perioperative care, major complications continue to be seen in patients undergoing major surgery. Enhanced recovery after surgery (ERAS) protocols are perioperative car...
Eligibility Criteria
Inclusion
- Patients between 18-80 years of
- Patients underwent elective thoracic surgery,
- American Society of Anesthesiologists (ASA) I-II-III
- Body mass index (BMI) between 18.5-35 kg/m2
Exclusion
- Patients with systemic inflammatory diseases
- Patients with a history of anti-inflammatory and anti-allergic drugs,
- Patients with a history of corticosteroid usage,
- Patients who had received intraoperative blood product transfusions,
- Patients who had previously undergone thoracic surgery,
- Patients with missing data
Key Trial Info
Start Date :
March 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 16 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05329311
Start Date
March 16 2022
End Date
June 16 2022
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Atatürk Chest Disease and Chest Surgery Training and Research Hospital
Keçiören, Ankara, Turkey (Türkiye), 06000